Related Experiment Video
Updated: Oct 4, 2025
Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
Cellular senescence and the skeleton: pathophysiology and therapeutic implications
Abstract:
Cellular senescence is a fundamental aging mechanism that is currently the focus of considerable interest as a pathway that could be targeted to ameliorate aging across multiple tissues, including the skeleton. There is now substantial evidence that senescent cells accumulate in the bone microenvironment with aging and that targeting these cells prevents age-related bone loss, at least in mice. Cellular senescence also plays important roles in mediating the skeletal fragility associated with diabetes mellitus, radiation, and chemotherapy. As such, there are ongoing efforts to develop "senolytic" drugs that kill senescent cells by targeting key survival mechanisms in these cells without affecting normal cells. Because senescent cells accumulate across tissues with aging, senolytics offer the attractive possibility of treating multiple age-related comorbidities simultaneously.
Insights
Cellular senescence, a key aging process, drives bone loss and fragility. Targeting senescent cells with senolytics shows promise for treating age-related bone conditions and other diseases.
Area of Science:
- Gerontology and regenerative medicine
- Skeletal biology and aging research
Background:
- Cellular senescence is a fundamental aging mechanism implicated in tissue degeneration.
- Senescent cells accumulate in aging bone, contributing to bone loss and fragility.
- Senescence also mediates skeletal issues in conditions like diabetes, radiation, and chemotherapy.
Purpose of the Study:
- To explore cellular senescence as a therapeutic target for age-related bone conditions.
- To investigate the role of senescent cells in skeletal aging and fragility.
- To highlight the potential of senolytic drugs for treating multiple age-related diseases.
Main Methods:
- Review of existing evidence on cellular senescence in bone aging.
- Analysis of the role of senescent cells in age-related bone loss and fragility.
- Discussion of senolytic drug development targeting senescent cell survival mechanisms.
Main Results:
- Substantial evidence indicates senescent cell accumulation in the aging bone microenvironment.
- Targeting senescent cells has shown efficacy in preventing age-related bone loss in preclinical models.
- Cellular senescence is a significant factor in skeletal fragility linked to various conditions.
Conclusions:
- Senescent cells are a viable therapeutic target for ameliorating aging across multiple tissues, particularly the skeleton.
- Senolytics offer a promising strategy for simultaneously treating multiple age-related comorbidities.
- Further development of senolytic therapies could revolutionize the management of age-related bone diseases and systemic aging.
Related Concept Videos
01:19The Effect of Aging on Tissues
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:26Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:37Mitochondria
01:40Bone Remodeling
02:41Telomeres and Telomerase